ADVERTISEMENT
ADVERTISEMENT
New RNA-Based Tool Could Assess Preeclampsia Risk
New RNA-Based Tool Could Assess Preeclampsia Risk
Transcripts circulating in the blood provide real-time information about maternal, fetal, and placental health.
New RNA-Based Tool Could Assess Preeclampsia Risk
New RNA-Based Tool Could Assess Preeclampsia Risk

Transcripts circulating in the blood provide real-time information about maternal, fetal, and placental health.

Transcripts circulating in the blood provide real-time information about maternal, fetal, and placental health.

Illumina

Gary Schroth, Vice President at Illumina
Modern Multiomics: Why, How, and Where to Next?
The Scientist and Illumina | May 15, 2023 | 4 min read
A conversation with Illumina Distinguished Scientist and Vice President Gary Schroth about the present and future of multiomic technology and applications
Layered visual representation of multiomics
Integrate and Innovate with NGS and Multiomics
The Scientist and Illumina | May 4, 2023 | 6 min read
Researchers across disciplines combine layers of discovery obtained with accessible NGS-based multiomics approaches.
Illumina to Buy Pacific Biosciences for $1.2 Billion
Kerry Grens | Nov 6, 2018 | 1 min read
The purchase adds long-read sequencing to Illumina’s portfolio.
Nanopore Sequencing Lawsuit
Catherine Offord | Feb 29, 2016 | 1 min read
Illumina accuses Oxford Nanopore Technologies of developing nanopore-based sequencing strategies covered by its patents.
Same Day Genomes
Megan Scudellari | Jan 13, 2012 | 2 min read
Two new sequencing machines will read a human genome in 24 hours.
ADVERTISEMENT